Antidepressant Adequacy and Work Status Among Medicaid Enrollees with Disabilities: A Restriction-based, Propensity Score-adjusted Analysis
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
This cross-sectional study of adult survey respondents with disability and depression (n = 199) enrolled in Massachusetts’ Medicaid program examined the association of adequately or inadequately prescribed antidepressant treatment and self-reported work status using conditional logistic regression, controlling for age, gender, race, marital status, education, receipt of SSI/SSDI, self-reported disabling condition, and health status. Confounding by severity was addressed by two methods: restriction of our sample and subsequent stratification by propensity score. Individuals receiving adequate antidepressant treatment had an increased odds of working compared to individuals receiving inadequate treatment, both in analyses in which restriction was used to limit confounding (OR = 3.45, 95% CI = 1.15–10.32, P < .03), and in analyses which combined restriction with adjustment by propensity score stratification (OR = 3.04, 95% CI = 1.01–9.62, P < .05). Among this sample of Medicaid enrollees with disability and depression, those receiving adequate antidepressant treatment were significantly more likely to report working.
- Addington, D. D., Azorin, J. M., Falloon, I. R., Gerlach, J., Hirsch, S. R., & Siris, S. G. (2002). Clinical issues related to depression in schizophrenia: An international survey of psychiatrists. Acta Psychiatrica Scandinavica, 105, 189–195. doi:10.1034/j.1600-0447.2002.1o458.x. CrossRef
- Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., et al. (2003). Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year followup. The American Journal of Psychiatry, 160, 1252–1262. doi:10.1176/appi.ajp.160.7.1252. CrossRef
- American Psychiatric Association. (2000). American psychiatric association practice guidelines for the treatment of patients with major depressive disorder (2nd ed.). Arlington, VA: Author.
- American Psychiatric Association. (2004). Practice guidelines and resources for treatment of patients with Schizophrenia (2nd ed.). Arlington, VA: Author.
- Beasley, R., Burgess, C., Pearce, N., Woodman, K., & Crane, J. (1994). Confounding by severity does not explain the association between fenoterol and asthma death. Clinical and Experimental Allergy, 24, 660–668. doi:10.1111/j.1365-2222.1994.tb00970.x. CrossRef
- Braitman, L. E., & Rosenbaum, P. R. (2002). Rare outcomes, common treatments: Analytic strategies using propensity scores. Annals of Internal Medicine, 137, 693–696.
- Burton, W. N., Chen, C. Y., Conti, D. J., Schultz, A. B., & Edington, D. W. (2007). The association of antidepressant medication adherence with employee disability absences. The American Journal of Managed Care, 13, 105–112.
- Clark, S., Costantino, T., Rudnitsky, G., & Camargo, C. A. (2005). Observational study of intravenous versus oral corticosteroids for acute asthma: An example of confounding by severity. Academic Emergency Medicine, 12, 439–445. doi:10.1111/j.1553-2712.2005.tb01545.x. CrossRef
- Dewa, C. S., Hoch, J. S., Lin, E., Paterson, M., & Goering, P. (2003). Pattern of antidepressant use and duration of depression-related absence from work. The British Journal of Psychiatry, 183, 507–513. doi:10.1192/bjp.183.6.507. CrossRef
- Emptage, N. P., Strun, R., & Robinson, R. L. (2005). Depression and comorbid pain as predictors of disability, employment, insurance status and health care costs. Psychiatric Services (Washington, D.C.), 56, 468–474. doi:10.1176/appi.ps.56.4.468.
- Garrett, J. E., Lanes, S. F., Kolbe, J., & Rea, H. H. (1996). Risk of severe life threatening asthma and beta agonist type: An example of confounding by severity. Thorax, 51, 1093–1099. doi:10.1136/thx.51.11.1093. CrossRef
- Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., et al. (2003). The economic burden of depression in the United States: How did it change between 1990 and 2000? The Journal of Clinical Psychiatry, 64, 1465–1475.
- Henry, A. D., Gallagher, P., Stringfellow, V., Olin, L., Hooven, F., & Himmelstein, J. (2007). Notes from the field: Contemporary strategies for developing surveys of people with disabilities. The MassHealth employment and disability survey. In T. Kroll, D. Kerr, P. Placek, J. Cyril, & G. Hendershot (Eds.), Towards best practices for surveying people with disabilities (Vol. 1, pp. 127–146). Hauppauge, NY: Nova Science Publishers.
- Henry, A.D., Hooven, F., Averbach, A., Hashemi, L., Zhang, J., Olin, L., et al.(2005). Disability and employment: Findings from the MassHealth employment and disability survey. Final report for Massachusetts medicaid infrastructure and comprehensive employment opportunities grant, Center for Health Policy and Research, University of Massachusetts Medical School.
- Henry, A. D., Hooven, F., Hashemi, L., Banks, S., Clark, R., & Himmelstein, J. (2006). Disabling conditions and work outcomes among enrollees in a Medicaid buy-in program. Journal of Vocational Rehabilitation, 25(2), 107–117.
- Joffe, M. M., & Colditz, G. A. (1998). Restriction as a method for reducing bias in the estimation of direct effects. Statistics in Medicine, 17, 2233–2249. doi:10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0. CrossRef
- Kessler, R. C., Barber, C., Birnbaum, H. G., Frank, R. C., Greenberg, P. E., Rose, R. M., et al. (1999). Depression in the workplace: Effects on short-term disability. Health Affairs, 18, 163–171. doi:10.1377/hlthaff.18.5.163. CrossRef
- Kinne, S., Patrick, D. L., & Doyle, D. L. (2004). Prevalence of secondary conditions among people with disabilities. American Journal of Public Health, 94, 443–445. doi:10.2105/AJPH.94.3.443. CrossRef
- Kronick, R., Gilmer, T., Dreyfus, T., & Lee, L. (2000). Improving health-based payment for medicaid beneficiaries: CDPS. Health Care Financing Review, 21(3), 29–64.
- McDermott, S., Moran, R., Platt, T., & Dasari, S. (2006). Variation in health conditions among groups of adults with disabilities in primary care. Journal of Community Health, 31, 147–159. doi:10.1007/s10900-005-9008-y. CrossRef
- McNeil, J. (2001). Americans with disabilities: Household economic studies, 1997. Washington, DC: US Department of Commerce, Economics and Statistics Administration, US Census Bureau.
- Mintz, J., Mintz, L. I., Arruda, M. J., & Hwang, S. S. (1992). Treatments of depression and the functional capacity to work. Archives of General Psychiatry, 49, 761–768.
- Mitra, M., Wilber, N., Allen, D., & Walker, D. K. (2005). Prevalence and correlates of depression as a secondary condition among adults with disabilities. The American Journal of Orthopsychiatry, 75, 76–85. doi:10.1037/0002-94220.127.116.11. CrossRef
- Oquendo, M. A., Baca-Garcia, E., Kartachov, A., Khait, V., Campbell, C. E., Richards, M., et al. (2003). A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. The Journal of Clinical Psychiatry, 64, 825–833. CrossRef
- Sachs, G., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., et al. (2007). Effectiveness of adjunctive antidepressant treatment for bipolar depression. The New England Journal of Medicine, 356, 1711–1722. doi:10.1056/NEJMoa064135. CrossRef
- SAS Institute, Inc. (2002–2003). SAS for windows, version 9.1. Cary NC: Author.
- Schneeweiss, S., Patrick, A. R., Sturmer, T., Brookhart, M. A., Avorn, J., Maclure, M., et al. (2007). Increasing levels of restriction in pharmacoepidemiologic database studies of elederly and comparison with randomized trial results. Medical Care, 45, S131–S142. doi:10.1097/01.mlr.0000244636.54588.2b. CrossRef
- Schoenbaum, M., Unutzer, J., McCaffrey, D., Duan, N., Sherbourne, C., & Wells, K. B. (2002). The effects of primary care depression treatment on patients’ clinical status and employment. Health Services Research, 37, 1145–1158. doi:10.1111/1475-6773.01086. CrossRef
- Sepehry, A. A., Potvin, S., Elie, R., & Stip, E. (2007). Selective serotonin reuptake inhibitor (SSRI) Add-on therapy for the negative symptoms of schizophrenia: A meta-analysis. The Journal of Clinical Psychiatry, 68, 604–610. CrossRef
- Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., et al. (2006). A meta-analysis of the association between adherence to drug therapy and mortality. British Medical Journal, 333, 15–18. doi:10.1136/bmj.38875.675486.55. CrossRef
- Stein, M. B., Cox, B. J., Afifi, T. O., Belik, S.-L., & Sareen, J. (2006). Does co-morbid depressive illness magnify the impact of chronic physical illnesses? A population-based perspective. Psychological Medicine, 36, 587–596. doi:10.1017/S0033291706007239. CrossRef
- Stewart, W. F., Ricci, J. A., Chee, E., Hahn, S. R., & Morganstein, D. (2003). Cost of lost productive work time among US workers with disabilities. Journal of the American Medical Association, 289, 3135–3144. doi:10.1001/jama.289.23.3135. CrossRef
- U. S. Department of Health, Human Services. (2005). The Surgeon General’s call to action to improve the health and wellness of persons with disabilities. Washington, DC: Author.
- Waghorn, G., Chant, D., & Lloyd, C. (2006). Labor force activity among Australians with musculoskeletal disorders comorbid with depression and anxiety disorders. Journal of Occupational Rehabilitation, 16, 241–252. doi:10.1007/s10926-006-9018-3. CrossRef
- Wang, J., & Donnan, P. T. (2001). Propensity score methods in drug safety studies: Practice, strengths, and limitations. Pharmacoepidemiology and Drug Safety, 10, 341–344. doi:10.1002/pds.656. CrossRef
- Antidepressant Adequacy and Work Status Among Medicaid Enrollees with Disabilities: A Restriction-based, Propensity Score-adjusted Analysis
Community Mental Health Journal
Volume 45, Issue 5 , pp 333-340
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Antidepressant treatment
- Propensity score
- Author Affiliations
- 1. Center for Psychopharmacologic Research and Treatment, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA, 01655, USA
- 2. Center for Health Policy and Research (CHPR), University of Massachusetts Medical School, 333 South Street, Shrewsbury, MA, 01545, USA
- 3. Center for Outcomes Research, University of Massachusetts Medical School, Biotech 3, One Innovation Drive, Suite 110, Worcester, MA, 01605, USA
- 4. Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA, USA